Long-term safety and efficacy of tralokinumab in adolescents with moderate-to-severe atopic dermatitis: an interim analysis of ECZTEND

被引：0
|
作者：
Simpson, Eric [1 ]
Paller, Amy [2 ]
Wollenberg, Andreas [3 ]
Bewley, Anthony [4 ]
Cork, Michael [5 ,6 ]
Hong, Chih-Ho [7 ]
Soong, Weily [8 ]
Almgren, Peter [9 ]
Carlsson, Anna [9 ]
Blauvelt, Andrew [10 ]
机构：
[1] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR USA
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[3] Ludwig Maximilian Univ Munich, Dept Dermatol & Allergy, Munich, Germany
[4] Barts Hlth NHS Trust, London, England
[5] Univ Sheffield, Sheffield Dermatol Res, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England
[6] Sheffield Teaching Hosp, NIHR Clin Res Facil, Sheffield, S Yorkshire, England
[7] Univ British Columbia, Vancouver, BC, Canada
[8] AllerVie Hlth, Alabama Allergy & Asthma Ctr, Birmingham, AL USA
[9] LEO Pharma AS, Ballerup, Denmark
[10] Oregon Med Res Ctr, Portland, OR USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB190 / AB190
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis
    Khattri, S.
    Brunner, P. M.
    Garcet, S.
    Finney, R.
    Cohen, S. R.
    Oliva, M.
    Dutt, R.
    Fuentes-Duculan, J.
    Zheng, X.
    Li, X.
    Bonifacio, K. M.
    Kunjravia, N.
    Coats, I.
    Cueto, I.
    Gilleaudeau, P.
    Sullivan-Whalen, M.
    Suarez-Farinas, M.
    Krueger, J. G.
    Guttman-Yassky, E.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S41 - S41
  • [42] Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis
    Cork, M. J.
    Eichenfield, L. F.
    Blauvelt, A.
    Rosmarin, D.
    Hussain, I.
    Davis, J. D.
    Li, M.
    Zhang, Q.
    Gadkari, A.
    Eckert, L.
    Kamal, M. A.
    Bansal, A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S104 - S104
  • [43] Efficacy and safety of 611 for the treatment of moderate-to-severe atopic dermatitis in adults
    Zhang, Jianzhong
    Zhao, Yan
    Zhou, Qinghong
    Xu, Yuyu
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : I54 - I55
  • [44] Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis The Phase 3 ECZTRA 6 Randomized Clinical Trial
    Paller, Amy S.
    Flohr, Carsten
    Cork, Michael
    Bewley, Anthony
    Blauvelt, Andrew
    Hong, H. Chih-ho
    Imafuku, Shinichi
    Schuttelaar, Marie L. A.
    Simpson, Eric L.
    Soong, Weily
    Arlert, Petra
    Lophaven, Katja Wendicke
    Kurbasic, Azra
    Soldbro, Lise
    Vest, Natacha Strange
    Wollenberg, Andreas
    [J]. JAMA DERMATOLOGY, 2023, 159 (06) : 596 - 605
  • [45] Efficacy and safety of tralokinumab monotherapy in North American adult patients with moderate-to-severe atopic dermatitis: A subanalysis of the ECZTRA 2 trial
    Wiseman, Marni
    Armstrong, April W.
    Soung, Jennifer
    Albrecht, Lorne
    Lomaga, Mark
    Papp, Kim A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB178 - AB178
  • [46] Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis
    BerthJones, J
    GrahamBrown, BAC
    Marks, B
    Camp, RDR
    English, JSC
    Freeman, K
    Holden, CA
    Rogers, SCF
    Oliwiecki, S
    Friedmann, PS
    LewisJones, MS
    Archer, CB
    Adriaans, B
    Douglas, WS
    Allen, BR
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1997, 136 (01) : 76 - 81
  • [47] Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical Trial
    Zhao, Yan
    Li, Jing-Yi
    Yang, Bin
    Ding, Yang-Feng
    Wu, Li-Ming
    Zhang, Li-Tao
    Wang, Jin-Yan
    Lu, Qian-Jin
    Zhang, Chun-Lei
    Zhang, Fu-Ren
    Zhu, Xiao-Hong
    Li, Yu-Mei
    Tao, Xiao-Hua
    Diao, Qing-Chun
    Li, Lin-Feng
    Lu, Jian-Yun
    Man, Xiao-Yong
    Li, Fu-Qiu
    Xia, Xiu-Juan
    Song, Jiao-Ran
    Jia, Ying-Min
    Zhang, Li-Bo
    Chen, Bo
    Zhang, Jian-Zhong
    [J]. BIODRUGS, 2024, 38 (05) : 681 - 689
  • [48] Efficacy and safety of abrocitinib in adolescents with moderate-to-severe atopic dermatitis from the JADE clinical trial program
    Eichenfield, Lawrence F.
    Flohr, Carsten
    Bangert, Christine
    Irvine, Alan D.
    Weidinger, Stephan
    Nesnas, John
    Koppensteiner, Herwig
    Zhang, Fan
    Rojo, Ricardo
    Chan, Gary
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [49] Efficacy and safety of abrocitinib in adolescents with moderate-to-severe atopic dermatitis from the JADE clinical trial programme
    Eichenfield, L. F.
    Flohr, C.
    Bangert, C.
    Irvine, A. D.
    Weidinger, S.
    Nesnas, J.
    Koppensteiner, H.
    Zhang, F.
    Rojo, R.
    Chan, G.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E142 - E143
  • [50] EFFICACY AND SAFETY OF ABROCITINIB MONOTHERAPY IN ADULTS AND ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A POST HOC ANALYSIS OF JADE REGIMEN
    Flohr, Carsten
    Cork, Michael J.
    Eichenfield, Lawrence F.
    Feeney, Claire
    Koppersteiner, Herwig
    Lazariciu, Irina
    Nesnas, John
    [J]. ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 31 - 31
12345